Utama › Penyakit Paru-paru › Utah
Kajian klinikal Penyakit Paru-paru di Utah
7 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi di Utah.
Bandar di Utah
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Salt Lake City
- Research Site, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
- J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Alpine Research Organization, Clinton
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT07730450Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT05297734A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.